Denali Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by Citigroup
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.0M | 141k | 21.46 |
2023-09-30 | $2.9M | 138k | 20.63 |
2023-03-31 | $4.8M | 208k | 23.04 |
2022-12-31 | $3.6M | 128k | 27.81 |
2022-09-30 | $6.9M | 193k | 35.71 |
2021-12-31 | $5.4M | 120k | 44.60 |
2021-03-31 | $4.0M | 70k | 57.10 |
2020-12-31 | $1.5M | 18k | 83.77 |
2020-09-30 | $249k | 6.9k | 35.86 |
2020-06-30 | $0 | 50k | 0.00 |
2020-03-31 | $663k | 38k | 17.51 |
2019-12-31 | $305k | 18k | 17.41 |
2019-09-30 | $1.2M | 79k | 15.32 |
2019-06-30 | $1.3M | 65k | 20.76 |
2019-03-31 | $279k | 12k | 23.27 |
2018-12-31 | $1.8M | 89k | 20.66 |
2018-09-30 | $279k | 13k | 21.73 |
2018-06-30 | $37k | 2.4k | 15.25 |
2018-03-31 | $45k | 2.3k | 19.64 |